TransCode Therapeutics 株価情報 (NASDAQ: RNAZ)

最新ニュース TransCode Therapeutics (NASDAQ:RNAZ) 株価情報

TransCode Therapeutics

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics Inc

Trading Ideas

NVNI

Nvni Group Shares Resume Trade

BPTH

Bio-Path Shares Halted On Circuit Breaker, Stock Now Up 278.2%

Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) and Pegasus Airlines today announced Türkiye's leading low-cost carrier will grow and modernize its single-aisle fleet with an order for up to 200 737 MAX airplanes. The airline's purchase includes a firm order for 100 737-10 jets – plus options for 100 more.
The largest model in the 737 MAX family, the 737-10 can carry as many as 230 passengers with a range of up to 5,740 km (3,100 nautical miles), while reducing fuel use and emissions by 20% compared to the airplanes it replaces. The airplane's efficiency and flexibility will enable Pegasus Airlines to serve more passengers on more routes with the lowest cost per seat of any single-aisle airplane.

News

Contracts

Pegasus Airlines Orders Up To 200 Boeing 737-10 Airplanes; Purchase Includes A Firm Order For 100 737-10 Jets, Plus Options For 100 More

RBC Capital analyst Arun Viswanathan downgrades Pactiv Evergreen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTVE#NASDAQ">PTVE</a>) from Outperform to Sector Perform and raises the price target from $14 to $18.

Downgrades

Price Target

Analyst Ratings

PTVE

RBC Capital Downgrades Pactiv Evergreen to Sector Perform, Raises Price Target to $18

President-elect Donald Trump stirred the pot on Thursday by advocating for the outright removal of the U.S. debt ceiling, a move that sent shockwaves through the bond market and <a href="https://www.benzinga.com/markets">tempered Wall Street gains.</a>
Trump's remarks came as Congress scrambled to pass a funding bill to avoid a government shutdown just days before the deadline.
In a phone interview with NBC News, Trump didn't mince words, calling the debt ceiling "a meaningless concept" and advocating for its elimination. 
"The Democrats have said they want to get rid of it. If they want to get rid of it, I would lead the charge," Trump told NBC News.
According to Trump, the statutory limit on how much the U.S. government can borrow to meet its financial obligations &#8220;doesn't mean anything, except psychologically,&#8221; and getting rid of it would be the "smartest thing [Congress] could do.&#8221;
<h3 class="wp-block-heading">How Could US Congress Get Rid Of The Debt Ceiling?</h3>
To abolish the debt ceiling, Congress would need to pass a new law explicitly repealing or replacing the existing statute that sets borrowing limits. This requires a simple majority vote in both the House of Representatives and the Senate. 
In the House, that typically means 218 votes out of 435 members, assuming all members vote. In the Senate, where there are 100 seats, it takes 51 votes to pass a bill—or 50 votes plus the Vice President's tie-breaking vote if the chamber is evenly divided.
Yet, the Senate's infamous filibuster rule complicates things. Without using the budget reconciliation process (a special mechanism reserved for fiscal matters), a bill to eliminate the debt ceiling would need 60 votes in the Senate to overcome a filibuster.
Once the bill passes through Congress, it needs presidential approval to become law. 
Should the President veto it –&nbsp;a situation highly unlikely according to what Trump revealed – Congress would face an even steeper challenge: overriding the veto would require a two-thirds majority in both chambers, or 290 votes in the House and 67 votes in the Senate.
<h3 class="wp-block-heading">Goldman Sachs: Shutdown Unlikely To Drag On</h3>
Goldman Sachs economist Alec Philips highlighted that a government shutdown, while disruptive, is unlikely to persist for long. 
"We estimate that a shutdown would reduce GDP growth in the quarter by 0.15 percentage points for each week it lasted and would boost GDP growth by the same amount in the quarter following government reopening," Philips said.
Yet, Philips also acknowledged that the disruption wouldn't be without its pain points, particularly for federal employees and government contractors, who might bear the brunt of the fallout in real-time.
According to the economist, two potential paths have emerged. 
First, Republicans could tie a debt limit increase to the spending bill set for March 2025, although this would likely require concessions from Democrats, such as a $20 billion annual extension of ACA insurance premium subsidies. 
Alternatively, Republicans may pursue a debt limit suspension through an early 2025 budget reconciliation bill focused on immigration enforcement.
However, the success of these strategies is uncertain, as both approaches hinge on complex political negotiations.
<h3 class="wp-block-heading">Market reactions: Bonds fears spill over to Wall Street</h3>
Long-dated Treasuries, the asset class most sensitive to debt ceiling developments, reacted sharply to the news of Trump's call to eliminate the borrowing cap. Bond investors weren't thrilled, and their response was clear: yields on 30-year Treasury bonds surged 7 basis points to 4.75%, reaching their highest levels since May 2024.
The spike in yields hammered the popular iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>), which tumbled 1.5%, revisiting its April 2024 lows and flirting with its worst levels in over a year. This selloff reflects growing concerns over the possibility of unchecked government spending, which could fuel larger deficits and inflationary pressures.
Equities didn't escape unscathed either. The broader U.S. stock market lost steam as major indices pared their session gains. 
The S&amp;P 500—tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)—dropped 0.5%, or 150 points, following the news. 
Investors worried that removing the debt ceiling could stoke inflation and force the Federal Reserve into a more hawkish stance, generating further uncertainty in the path of rate cuts ahead. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42563299/feds-powell-shocks-markets-its-a-new-phase-were-significantly-closer-to-neutral">Fed&#8217;s Powell Shocks Markets After Interest Rate Cut: &#8216;It&#8217;s A New Phase&#8217;</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Regulations

Politics

Treasuries

Econ #s

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

Trump Would 'Lead The Charge' To Scrap Debt Ceiling: 30-Year Treasury Bonds Slide To 2024 Lows, Stocks Cut Gains

Movers

Bio-Path Holdings Shares Resume

XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 201.1%

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Compass Point analyst David Rochester maintains American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) with a Neutral and raises the price target from $315 to $325.

Compass Point Maintains Neutral on American Express, Raises Price Target to $325

WIIM

OMER

Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit  its narsoplimab Biologics License Application to the FDA.

Nvni Group Shares Resume Trade, Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 134.4%

Commodities

Markets

US Natural Gas Storage: -125B vs -123B Est.

Canaccord Genuity analyst Brian McNamara maintains Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) with a Hold and raises the price target from $46 to $49.

Canaccord Genuity Maintains Hold on Worthington Enterprises, Raises Price Target to $49

BigBear.ai Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) shares are trading higher Thursday after the company announced it secured a contract for <a href="https://www.benzinga.com/quote/BBAI">federal civilian and defense agencies</a>.
What Happened: BigBear.AI said it was awarded a position on the U.S. General Services Administration&#8217;s OASIS+ Unrestricted Multiple Agency Contract.
OASIS+ is a government-wide suite of contracts designed to streamline the procurement of complex professional services across all federal agencies.&nbsp;The company&#8217;s multiple-award contract has no maximum dollar ceiling and offers a 10-year ordering period with an unlimited number of task orders at any dollar value.
&#8220;This milestone underscores our proven track record of delivering innovative solutions that merge deep expertise with cutting-edge technology. Through OASIS+, we look forward to expanding our reach and impact across critical federal missions while strengthening our partnerships with existing customers,&#8221; said Mandy Long, CEO of BigBear.AI. 
The award includes 75 contract line items numbers across five domains including management and advisory, technical and engineering, research and development, intelligence services and logistics. 
See Also: <a href="https://www.benzinga.com/24/12/42586612/accenture-delivers-q1-revenue-growth-bolstered-by-consulting-and-managed-services">Accenture Q1 Earnings: Revenue And EPS Beat Bolstered By Consulting And Managed Services, Raises Annual Revenue Outlook</a>
Separately, BigBear.AI announced that it exchanged a portion of its existing 6% convertible senior notes due 2026 for new 6% convertible notes due 2029. The company will exchange approximately&nbsp;$182.3 million&nbsp;in aggregate principal amount of the existing notes for&nbsp;$182.3 million of the new notes and approximately $400,000 in cash. 
The exchange transactions are expected to settle on or about Dec. 27. Upon completion, the aggregate amount of the existing notes outstanding will be approximately $17.7 million. BigBear.AI will not receive any cash proceeds from the issuance of new convertible notes. 
BBAI Price Action: BigBear.AI shares were up 6.52% at $1.11 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using artificial intelligence via Midjourney.

BBAI

What's Going On With BigBear.AI Stock Thursday?

Whales with a lot of money to spend have taken a noticeably bullish stance on IonQ.
Looking at options history for IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $173,554 and 17, calls, for a total amount of $958,866.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $55.0 for IonQ during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for IonQ's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across IonQ's significant trades, within a strike price range of $20.0 to $55.0, over the past month.
<h3>IonQ Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734622252_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.4</td>
<td>$4.15</td>
<td>$4.4</td>
<td>$50.00</td>
<td>$219.9K</td>
<td>5.3K</td>
<td align="right">969</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$25.3</td>
<td>$24.15</td>
<td>$24.95</td>
<td>$20.00</td>
<td>$174.6K</td>
<td>1.7K</td>
<td align="right">86</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.5</td>
<td>$5.45</td>
<td>$5.5</td>
<td>$40.00</td>
<td>$86.3K</td>
<td>1.4K</td>
<td align="right">45</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$15.65</td>
<td>$14.2</td>
<td>$15.1</td>
<td>$40.00</td>
<td>$75.5K</td>
<td>658</td>
<td align="right">60</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$21.25</td>
<td>$20.75</td>
<td>$21.25</td>
<td>$20.00</td>
<td>$63.7K</td>
<td>1.4K</td>
<td align="right">34</td>
</tr>
</tbody>
</table>

<h3>About IonQ</h3>
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.
<h3>Current Position of IonQ</h3>
<ul>
<li>Trading volume stands at 11,159,470, with IONQ's price up by 4.85%, positioned at $39.32.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 69 days.</li>
</ul>
<h3>What Analysts Are Saying About IonQ</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $50.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from DA Davidson has revised its rating downward to Buy, adjusting the price target to $50. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IonQ options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

IONQ

Decoding IonQ's Options Activity: What's the Big Picture?

Investors with a lot of money to spend have taken a bearish stance on IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IREN, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 13 options trades for IREN.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 61%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $42,586, and 12, calls, for a total amount of $771,930.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $6.0 to $20.0 for IREN over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for IREN's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of IREN's whale activity within a strike price range from $6.0 to $20.0 in the last 30 days. 
<h3>IREN Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734622246_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.4</td>
<td>$4.1</td>
<td>$4.2</td>
<td>$12.50</td>
<td>$210.0K</td>
<td>12.2K</td>
<td>1.4K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$10.00</td>
<td>$165.6K</td>
<td>28.8K</td>
<td>675</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.6</td>
<td>$4.2</td>
<td>$4.3</td>
<td>$12.50</td>
<td>$150.5K</td>
<td>12.2K</td>
<td>466</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.7</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$15.00</td>
<td>$87.5K</td>
<td>18.2K</td>
<td>280</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.7</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$15.00</td>
<td>$84.0K</td>
<td>18.2K</td>
<td>280</td>
</tr>
</tbody>
</table>

<h3>About IREN</h3>
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.
<h3>Present Market Standing of IREN</h3>
<ul>
<li>With a volume of 3,420,238, the price of IREN is down -0.91% at $12.02. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 56 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IREN options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

IREN

Smart Money Is Betting Big In IREN Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Quantum Computing.
Looking at options history for Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $284,800 and 4, calls, for a total amount of $822,158.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $2.5 to $30.0 for Quantum Computing during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Quantum Computing's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Quantum Computing's substantial trades, within a strike price spectrum from $2.5 to $30.0 over the preceding 30 days.
<h3>Quantum Computing Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734622240_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>QUBT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.5</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$30.00</td>
<td>$600.0K</td>
<td>883</td>
<td align="right">80</td>
</tr>
<tr>
<td>QUBT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$17.0</td>
<td>$15.9</td>
<td>$16.2</td>
<td>$2.50</td>
<td>$113.4K</td>
<td>1.5K</td>
<td align="right">264</td>
</tr>
<tr>
<td>QUBT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$9.0</td>
<td>$8.5</td>
<td>$8.7</td>
<td>$18.00</td>
<td>$113.1K</td>
<td>75</td>
<td align="right">205</td>
</tr>
<tr>
<td>QUBT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$9.6</td>
<td>$9.0</td>
<td>$9.35</td>
<td>$19.00</td>
<td>$93.5K</td>
<td>7</td>
<td align="right">105</td>
</tr>
<tr>
<td>QUBT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$15.2</td>
<td>$14.3</td>
<td>$15.0</td>
<td>$5.00</td>
<td>$67.5K</td>
<td>10.0K</td>
<td align="right">50</td>
</tr>
</tbody>
</table>

<h3>About Quantum Computing</h3>
Quantum Computing Inc is an American company utilizing non-linear quantum optics (optical devices whose output due to quantum effects is exponentially, not linearly, related to inputs) to deliver quantum products for high-performance computing applications. QCi's products are designed to operate at room temperature and use low power at an affordable cost. The Company's portfolio of core technology and products offer new capabilities in the areas of high-performance computing, artificial intelligence, cyber security as well as remote sensing applications.
After a thorough review of the options trading surrounding Quantum Computing, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Quantum Computing</h3>
<ul>
<li>Trading volume stands at 48,943,180, with QUBT's price down by -28.74%, positioned at $18.3.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 102 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Quantum Computing, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

QUBT

This Is What Whales Are Betting On Quantum Computing

<a href="https://www.benzinga.com/startups/24/10/41544980/mark-cuban-breaks-silence-on-harris-tax-plan-criticizes-key-provision-during-campaign-stop-in-suppor">Mark Cuban</a> doesn't care for golf, but he's betting $1 million on a portable version of the game anyway. Recently on Shark Tank, Cuban surprised everyone by investing in BucketGolf, a customizable backyard-friendly game created by San Francisco siblings Tyler and Jenny Simmons.
BucketGolf ditches manicured greens and golf carts in favor of collapsible buckets, which serve as holes players can place wherever they want – on beaches, in parks or across backyards. The sets are priced between $114.99 and $254.99, with higher-end options featuring light-up holes and multiple clubs for added fun.
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
Despite Cuban's blunt admission – "I hate golf. I hate the concept of it" – the company's financials made it impossible to ignore.&nbsp;
On the show, CEO Tyler Simmons said the startup was on track to generate over $12 million in sales for 2024, doubling its $5.9 million revenue from 2023 and a far cry from $2.5 million in 2022. Profits account for roughly 15% to 20% of sales this year.
According to Statista, the U.S. outdoor games and sports market was valued at $37 billion in 2023 and has experienced steady annual growth, highlighting ample opportunity for innovative products like BucketGolf.
See Also: Deloitte's fastest-growing software company partnered with Amazon, Walmart &amp; Target announces the deadline to invest this year is 12/20. – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a>
The Simmons siblings entered the tank asking for $1 million in exchange for 10% equity, hoping to use the investment to expand inventory and prevent stockouts during busy seasons. "We have yet to make it through a busy season without running out of some of our best products," Tyler explained.
The pitch lit up the Sharks' interest, sparking a rare bidding war. <a href="https://www.benzinga.com/personal-finance/24/09/40714364/survive-anything-kevin-oleary-claims-you-need-5-million-in-savings-heres-how-you-can-reach-that-">Kevin O'Leary</a> offered $1 million for 25% equity, which Daymond John quickly matched.&nbsp;
John, who humorously admitted he'd never been much of a golfer, said, "This, I can actually see that I would like … I can say to my friends and family, ‘Come on over, we'll play that.'" Lori Greiner joined in with a bid of $1 million for 22.5% equity with preferred stock.
Cuban, true to form, waited in silence as the others fought it out – then swooped in with a strategic offer: $1 million for 15% equity, noticeably less than his competitors demanded. Lori Greiner quipped, "He always undercuts us. He sits and waits until the last moment."&nbsp;
It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Cuban defended his move, confidently adding, "Just the fact that I hate golf and I'm going to do videos of doing this … we can do demos at PGA events. There's a lot of ways to build visibility."
The siblings countered Cuban's terms, asking for 12.5% equity instead.&nbsp;
They compared their product's potential to Spikeball, the wildly popular backyard game that appeared on Shark Tank in 2015. Cuban famously passed on investing in Spikeball, later calling it "the one that got away" during an interview on Hart to Heart. Not about to repeat history, Cuban stood his ground.
As negotiations hit a standstill, Lori Greiner caved and accepted the siblings' counteroffer – prompting Cuban to match it. Ultimately, the Simmons chose Cuban as their partner. "We felt he had a little bit more of a sports background," Tyler said. "He is the perfect partner for us to take this to a whole new level."
It remains unclear whether the deal closed after taping. CNBC Make It reported that BucketGolf didn't respond to their request for comment.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones.  <a href="https://www.benzinga.com/money/mode-mobile-2">The deadline to invest and receive your shares this year is 12/20. Join 30,000+ shareholders and invest at $0.26/share today.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

Shark Tank's Mark Cuban Backs Portable Golf Game Despite His Hate For Golf – 'I'll Do Videos Of This, Even At A PGA Event!'

Cleanspark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) has outperformed the market over the past 5 years by 4.28% on an annualized basis producing an average annual return of 17.23%. Currently, Cleanspark has a market capitalization of $3.26 billion. 
Buying $100 In CLSK: If an investor had bought $100 of CLSK stock 5 years ago, it would be worth $214.06 today based on a price of $11.62 for CLSK at the time of writing.
<h3>Cleanspark's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734622209_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLSK

Here's How Much $100 Invested In Cleanspark 5 Years Ago Would Be Worth Today

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.47% to 42,525.10 while the NASDAQ rose 0.84% to 19,554.71. The S&amp;P 500 also rose, gaining, 0.62% to 5,908.52.
Check This Out: <a href="https://www.benzinga.com/24/12/42582254/top-3-consumer-stocks-you-may-want-to-dump-this-quarter">Top 3 Consumer Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 1.1% on Thursday.
In trading on Thursday, health care shares fell by 0.7%.
Top Headline
Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) posted better-than-expected earnings for its first quarter, while sales missed expectations.
The company said it sees second-quarter revenue of $7.9 billion, plus or minus $200 million, versus estimates of $9 billion. The company expects second-quarter adjusted earnings of $1.43 per share, plus or minus 10 cents per share, versus estimates of $1.92 per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>PainReform Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) shares shot up 532% to $13.85.</li>
<li>Shares of Trio Petroleum Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NASDAQ">TPET</a>)got a boost, surging 358% to $3.7550 after the company announced it will acquire the oil and gas assets in a heavy oil region of Saskatchewan, Canada for approximately $1.4 million.</li>
<li>Bio-Path Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares were also up, gaining 281% to $2.55 after the company announced preclinical testing of BP1001-A as a potential treatment for obesity in Type 2 diabetes patients by enhancing insulin sensitivity.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Snow Lake Resources Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) shares dropped 61% to $0.3185 as the company reported the pricing of public offering.</li>
<li>Shares of Aethlon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) were down 38% to $0.4070.</li>
<li>WANG &amp; LEE GROUP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) was down, falling 43% to $1.15.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $70.78 while gold traded down 1.7% at $2,607.90.
Silver traded down 4.6% to $29.315 on Thursday, while copper fell 1.5% to $4.0955.
Euro zone
European shares were lower today. The eurozone's STOXX 600 dipped 1.7%, Germany's DAX fell 1.3% and France's CAC 40 declined 1.3%. Spain's IBEX 35 Index fell 1.7%, while London's FTSE 100 fell 1.3%.
Asia Pacific Markets
Asian markets closed lower on Thursday, with Japan's Nikkei 225 falling 0.69%, Hong Kong's Hang Seng Index falling 0.56%, China's Shanghai Composite Index declining 0.36% and India's BSE Sensex falling 1.20%.
Economics
<ul>
<li>The Philadelphia Fed Manufacturing Index dipped to -16.4 in December compared to -5.5 in November and down from market expectations of 3.</li>
<li>The U.S. economy grew by an annualized rate of 3.1% in the third quarter compared to 2.8% in the second estimate and up from 3% in the previous quarter.</li>
<li>U.S. existing home sales gained by 4.8% from the previous month to an annualized rate of 4.15 million in November.</li>
<li>U.S. initial jobless claims declined by 22,000 to 220,000 in the first week of December, compared to market estimates of 230,000.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42591599/att-to-rally-more-than-33-here-are-10-top-analyst-forecasts-for-thursday">AT&amp;T To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>

Eurozone

Intraday Update

AEMD

LITM

PRFX

TPET

WLGS

US Stocks Higher, Micron Reports Downbeat Sales

Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rating on TransCode Therapeutics (RNAZ – Research Report) and keeping the price target a...

TransCode Therapeutics: Buy Rating Backed by Strategic Focus and Promising Phase 1 Study

TransCode Therapeutics to conduct reverse stock split

TransCode Therapeutics (RNAZ) has entered into a securities purchase agreement with certain institutional investors. The aggregate gross cash proce...

Transcode Therapeutics issues 21.2M shares at 37.7c in private placement

TransCode Therapeutics announces $8M private offering

TransCode Therapeutics ( ($RNAZ) ) has provided an update. TransCode Therapeutics has announced a 1-for-33 reverse stock split aimed at boosting it...

TransCode Therapeutics Announces Reverse Stock Split

TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 4

TransCode Therapeutics ( ($RNAZ) ) has shared an announcement. TransCode Therapeutics, Inc. recently executed a private placement agreement with in...

TransCode Therapeutics Raises $8M in Private Placement

19:50 EST Transcode Therapeutics (RNAZ) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-movi...

Transcode Therapeutics Inc trading halted, news pending

TransCode Therapeutics (RNAZ) announced that the Safety Review Committee, or SRC, monitoring its Phase 1 clinical trial has unanimously approved op...

Transcode announces SRC approved third cohort in TTX-MC138 clinical trial

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and Tra...

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), TransCode Therapeutics (RNAZ)

RNAZ

VKTX

Biotech

Press Releases

General

TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate's Preclinical Efficacy Against Metastatic Cancer

TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate

Health Care

TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

TransCode Therapeutics Open Letter to Shareholders

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

Financing

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Comments

TransCode Therapeutics

ニュース

最新ニュース TransCode Therapeutics (NASDAQ:RNAZ) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル